These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34849300)

  • 21. Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardioembolic stroke.
    Masjuan J; Salido L; DeFelipe A; Hernández-Antolín R; Fernández-Golfín C; Cruz-Culebras A; Matute C; Vera R; Pérez-Torre P; Zamorano JL
    Eur J Neurol; 2019 May; 26(5):816-820. PubMed ID: 30586229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of complications associated with percutaneous left atrial appendage closure with or without ablation: experience from 512 cases over a 4-year period.
    Zou Q; Jiang C; Lin P; Yu Y; Li J; Zhao F; Hu H; Sun S
    Front Cardiovasc Med; 2024; 11():1388024. PubMed ID: 39108669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left Atrial Appendage Closure in Patients with Atrial Fibrillation and Previous Intracerebral Hemorrhage.
    Renou P; Thambo JB; Iriart X; Nicot S; Kabore N; Jalal Z; Olindo S; Debruxelles S; Poli M; Rouanet F; Sibon I
    J Stroke Cerebrovasc Dis; 2017 Mar; 26(3):545-551. PubMed ID: 28041899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-stop hybrid procedure combining catheter ablation and left atrial appendage closure increases long-term risk for adverse events in patients with atrial fibrillation.
    Li XX; Tian Y; Shi L; Wang YJ; Zeng LJ; Huang LH; He SN; Li JP; Liu XP
    Pacing Clin Electrophysiol; 2020 Nov; 43(11):1358-1365. PubMed ID: 33000472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of left atrial appendage closure in non-valvular atrial fibrillation in patients over 75 years.
    Yu J; Chen H; Post F; Muenzel M; Keil T; Hou CR; Zhao M; Meng Z; Jiang L
    Heart Vessels; 2019 Nov; 34(11):1858-1865. PubMed ID: 31144099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboembolism after electrical isolation of the left atrial appendage: a new indication for interventional closure?
    Zender N; Weise FK; Bordignon S; Herrmann E; Konstantinou A; Bologna F; Nagase T; Chen S; Chun KRJ; Schmidt B
    Europace; 2019 Oct; 21(10):1502-1508. PubMed ID: 31230078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up.
    Phillips KP; Pokushalov E; Romanov A; Artemenko S; Folkeringa RJ; Szili-Torok T; Senatore G; Stein KM; Razali O; Gordon N; Boersma LVA
    Europace; 2018 Jun; 20(6):949-955. PubMed ID: 29106523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation.
    Reddy VY; Akehurst RL; Amorosi SL; Gavaghan MB; Hertz DS; Holmes DR
    Stroke; 2018 Jun; 49(6):1464-1470. PubMed ID: 29739915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of percutaneous atrial appendage closure followed by antiplatelet therapy in a high-risk population: single-center experience with a WATCHMAN device.
    Maksym J; Kapłon-Cieślicka A; Scisło P; Huczek Z; Marchel M; Piątkowski R; Kochman J; Opolski G; Grabowski M; Mazurek T
    Postepy Kardiol Interwencyjnej; 2023 Sep; 19(3):262-269. PubMed ID: 37854956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Residual flow may increase the risk of adverse events in patients received combined catheter ablation and transcatheter left atrial appendage closure for nonvalvular atrial fibrillation: a meta-analysis.
    Han Z; Wu X; Chen Z; Ji W; Liu X; Liu Y; Di W; Li X; Yu H; Zhang X; Xu B; Lan RF; Xu W
    BMC Cardiovasc Disord; 2019 Jun; 19(1):138. PubMed ID: 31182014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and Feasibility of Same-Day Discharge After Left Atrial Appendage Closure With the WATCHMAN Device.
    Tan BE; Boppana LKT; Abdullah AS; Chuprun D; Shah A; Rao M; Bhatt DL; Depta JP
    Circ Cardiovasc Interv; 2021 Jan; 14(1):e009669. PubMed ID: 33423538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.
    Kerneis M; Gibson CM; Chi G; Mehran R; AlKhalfan F; Talib U; Pahlavani S; Mir M; Bode C; Halperin JL; Nafee T; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Fox KAA; Cohen M
    JACC Cardiovasc Interv; 2018 Apr; 11(7):626-634. PubMed ID: 29550085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of left atrial appendage closure and catheter ablation in a single procedure for patients with atrial fibrillation: Multicenter experience.
    Du X; Chu H; Ye P; He B; Xu H; Jiang S; Lin M; Lin R; Liu J; Wang B; Feng M; Yu Y; Chen X
    J Formos Med Assoc; 2019 May; 118(5):891-897. PubMed ID: 30482569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous left atrial appendage closure using the LAmbre device in patients with atrial fibrillation and left atrial appendage thrombus.
    Jin LS; Ke JY; Lin YN; Li L; Fu JY; Chen YL; Qiu YX; Li XW; Pan YQ; Li YC
    Front Cardiovasc Med; 2022; 9():1071119. PubMed ID: 36505354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An under-recognized high-risk atrial fibrillation population: Analyzing transcatheter mitral valve repair patients for left atrial appendage closure device application.
    Lane CE; Eleid MF; Holmes DR
    Catheter Cardiovasc Interv; 2019 Aug; 94(2):274-279. PubMed ID: 30953408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.
    Faroux L; Cruz-González I; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Regueiro A; McInerney A; Mas-Lladó C; Estevez-Loureiro R; Laricchia A; O'Hara G; Rodés-Cabau J
    Int J Cardiol; 2021 Jun; 333():77-82. PubMed ID: 33647365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices.
    Weise FK; Bordignon S; Perrotta L; Konstantinou A; Bologna F; Nagase T; Chen S; Chun KRJ; Schmidt B
    EuroIntervention; 2018 Apr; 13(18):e2138-e2146. PubMed ID: 29400653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices.
    Wintgens LIS; Klaver MN; Swaans MJ; Alipour A; Balt JC; van Dijk VF; Rensing BJWM; Wijffels MCEF; Boersma LVA
    Europace; 2019 Mar; 21(3):428-433. PubMed ID: 30380015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-Year Outcome From Combining Cryoballoon Ablation and Left Atrial Appendage Closure: CLACBAC Study.
    Ren Z; Zhang J; Wang S; Jia P; Li X; Zhang J; Guo R; Li H; Li S; Yang H; Zheng Y; Meng W; Xu Y; Zhao D
    Front Cardiovasc Med; 2020; 7():610537. PubMed ID: 33505994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.